Login
Registrieren
Passwort zurücksetzen
Veröffentlichen & Verteilen
Verlagslösungen
Vertriebslösungen
Themen
Allgemein
Altertumswissenschaften
Architektur und Design
Bibliotheks- und Informationswissenschaft, Buchwissenschaft
Biologie
Chemie
Geowissenschaften
Geschichte
Industrielle Chemie
Informatik
Jüdische Studien
Kulturwissenschaften
Kunst
Linguistik und Semiotik
Literaturwissenschaft
Materialwissenschaft
Mathematik
Medizin
Musik
Pharmazie
Philosophie
Physik
Rechtswissenschaften
Sozialwissenschaften
Sport und Freizeit
Technik
Theologie und Religion
Wirtschaftswissenschaften
Veröffentlichungen
Zeitschriften
Bücher
Konferenzberichte
Verlage
Blog
Kontakt
Suche
EUR
USD
GBP
Deutsch
English
Deutsch
Polski
Español
Français
Italiano
Warenkorb
Home
Zeitschriften
Balkan Journal of Medical Genetics
Band 23 (2020): Heft 1 (June 2020)
Uneingeschränkter Zugang
β-Elemene inhibits the proliferation and migration of human glioblastoma cell lines
via
suppressing ring finger protein 135
M Alizada
M Alizada
,
J Li
J Li
,
H Aslami
H Aslami
,
D Yang
D Yang
,
T Korchuganova
T Korchuganova
und
YH Xu
YH Xu
| 26. Aug. 2020
Balkan Journal of Medical Genetics
Band 23 (2020): Heft 1 (June 2020)
Über diesen Artikel
Vorheriger Artikel
Nächster Artikel
Zusammenfassung
Artikel
Figuren und Tabellen
Referenzen
Autoren
Artikel in dieser Ausgabe
Vorschau
PDF
Zitieren
Teilen
Article Category:
Original Article
Online veröffentlicht:
26. Aug. 2020
Seitenbereich:
43 - 49
DOI:
https://doi.org/10.2478/bjmg-2020-0002
Schlüsselwörter
β-Elemene
,
Glioblastoma
,
Migration
,
Proliferation
,
Ring finger protein 135 (RNF135)
,
Tumorigenicity
© 2020 Alizada M, Li J, Aslami H, Yang D, Korchuganova T, Xu YH, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Figure 1
The expression level of RNF135 is suppressed in human glioblastoma cell lines U251, U118, U87 and A172 treated with β-elemene. The data from qRT-PCR (Author: see Abstract) of three independent experimental groups showed that the cell lines treated with β-elemene have a lower level of RNF 135 mRNA than the control group (p <0.05) (A-D). The data from Western blot also confirmed that protein levels of RNF135 were lower in the cell lines that were treated with β-elemene than those of the control group (E-H). Glyceraldehyde 3-phosphate dehydrogenase was used for both qRT-PCR and Western blot as loading control.
Figure 2
Increasing β-elemene treatment dose decreases viability of glioblastoma cells. Human glioblastoma cell lines U251, U118, U87 and A172 were sown at the concentration of 5000 cells per well in 96-well plates and treated with various doses (0, 20, 40, 60, 80 and 100 μg/mL) of β-elemene. The half maximal inhibitory effects (IC50) of the cells were obtained by doses of 47.44, 49.68, 58.41 and 57.36 μg/mL of β-elemene, respectively (A-D). The CCK-8 was utilized to ascertain cell viability and inhibitory effect of β-elemene on the proliferation of the cells. The results are shown as mean ± SD of the three experiments (p <0.05, the difference is statistically significant in the untreated control group).
Figure 3
Increasing the time of treatment with β-elemene decreases glioblastoma cells viability. The 5000 cells per well were sown in 96-well plates. Cell lines U251 and U118 were treated with 50 μg/mL β-elemene and cell lines U87 and A172 were treated with 60 μg/ mL β-elemene for 0, 24, 48, 72, 96, 120 and 144 hours (A-D). The CCK-8 was utilized to determine inhibitory effect of β-elemene on the proliferation of the cells in different time intervals. The results are shown as mean ± SD of the three experiments (p <0.05, the difference is statistically significant in the untreated control group).
Figure 4
Migration of human glioblastoma cell lines U251, U118, A172 and U87 were inhibited by β-elemene. In this wound healing assay, 5000 cells/well were sown into 6-well plates, cultured and photographed at the time intervals of 12, 24, 36 and 48 hours in at least three independent groups (β-elemene treated vs. control groups). The data were analyzed as mean ± SD and p <0.05. The human glioblastoma cells treated with β-elemene was found to have much lower speed moving to the gaps compared to the untreated control group cells (A-D).
Figure 5
β-Elemene suppresses U251 cell tumorigenicity in vivo. Five- to six-week old female nude mice were injected subcutaneously with (1 × 107) U251 cells and the tumor weights from the β-elemene-treated group and control group (untreated group) were measured at 28 days post-injection (A).The tumorigenicity of the U251 cells was remarkably reduced in the group that was treated with β-elemene as compared to the group that was not treated with β-elemene (p <0.05) (B). Immunohistochemistry staining of RNF135 of the tumors treated with β-elemene and not treated with β-elemene (control group), original magnification ×400, ×100 (C).
Vorschau